SPECIALIZED PRESS November 13, 2020 Not intended for U.S. and UK MediaPositive CHMP opinion for extension of rivaroxaban marketing authorization to treat venous thromboembolism (VTE) in childrenRead more
November 12, 2020 Metagenomi closes USD 65 million Series A financing led by Leaps by Bayer and Humboldt FundRead more
SPECIALIZED PRESS November 9, 2020 Not intended for U.S. and UK MediaBayer submits marketing authorization applications for finerenone in the U.S. and the EU for patients with chronic kidney disease and type 2 diabetesRead more
October 28, 2020 Bayer launches first Global Creative Council: raising the bar for the Consumer Health IndustryRead more
October 27, 2020 The U.S. EPA announces new 5-year registration for XtendiMax® herbicide, Bayer’s low-volatility dicamba productRead more
October 27, 2020 Bayer appoints Dr. Christian Rommel as new Head of Pharmaceuticals Research and DevelopmentRead more
October 27, 2020 60% of parents & parents-to-be do not realise that nutrition directly impacts a baby's growth and development during pregnancyRead more
October 26, 2020 Bayer acquires Asklepios BioPharmaceutical to broaden innovation base in cell and gene therapyRead more
SPECIALIZED PRESS October 26, 2020 Not intended for U.S. and UK MediaRivaroxaban application submitted to U.S. FDA for new indication in patients after lower-extremity revascularization due to symptomatic PADRead more
